Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
sleep drugs
Pharma
FDA rejects Vanda's Hetlioz for a 2nd time in jet lag disorder
For the second time, the FDA has rejected Vanda’s bid to expand the label for Hetlioz to treat jet lag disorder.
Kevin Dunleavy
Jan 8, 2026 11:20am
With $2.37B offer, Alkermes sweetens deal to acquire Avadel
Nov 19, 2025 9:53am
FDA leaves Harmony's Wakix expansion dreams in disarray
Feb 19, 2025 1:00pm
Jazz hunts for new CEO as longtime chief Cozadd eyes retirement
Dec 17, 2024 10:49am
Jazz backs AHA to bang the drum about sleep-heart disease link
Apr 3, 2023 7:15am
Idorsia taps Olympic skier Lindsey Vonn to pitch insomnia drug
Jul 25, 2022 7:24am
